Dr. Sher Bahadur Anjum
FRCPCH, MRCPCH, MRCPI, MD, DCH, MBBS
Founder & Executive Chair
Bio
Dr. Sher Bahadur Anjum is a Consultant Paediatrician and Haematologist at Barts Health NHS Trust, London, and Honorary Senior Lecturer at Queen Mary University London. He is the Founder and Executive Chair of the Global Thalassaemia Foundation.
Current Roles & Leadership:
- Lead for Haematology, Research & Paediatric High Dependency Unit at Barts Health NHS Trust
- Deputy Lead, Paediatric Oncology at Barts Health NHS Trust
- College Tutor, Royal College of Paediatrics and Child Health (2025 Present)
- Honorary Senior Lecturer, Queen Mary University London (2015 Present)
- Founder & Executive Chair, Global Thalassaemia Foundation
Key Achievements:
- Led the UK's first paediatric gene therapy for sickle cell disease at Newham Hospital in collaboration with Great Ormond Street Hospital (2025)
- Chief Investigator: CONS Study (2021) & PRECISE Trial (2025)
- Principal/Co-Investigator: SHIELD, DEEP, POPS & SPRING clinical trials
- Sole UK recruiter for GBT sickle cell trial & Led global recruitment for SHIELD trial
Awards & Honours:
- Education Innovation Award at Barts Health NHS Trust (2025)
- Outstanding Teacher Award at Barts Health NHS Trust (2025)
- Clinical Supervisor Award at Barts Health NHS Trust (2025)
- Unsung Hero Award at Barts Health NHS Trust (2025)
- Dean's Award at Queen Mary University London (2015)
- Excellent Researcher Award at Barts Research Faculty (2015)
- Gold Medal by Government of KPK (1992) for Welfare Work